Nutrition & Cancer 2024-2026

Thursday, August 29, 2024, 12:00 AM - Friday, August 28, 2026, 11:59 PM


AMA PRA Category 1 Credits™ (12.25 hours), Non-Physician Attendance (12.25 hours)

This course covers emerging research in the interplay between nutrition and cancer and offers insights into the role of nutrition in three common cancers: breast, colorectal, and prostate. The course stresses advancements in the understanding of carcinogenesis, individualization of nutrition, and cancer treatment and offers an updated take on the role of nutrition during cancer prevention, treatment, and survivorship. The understanding of carcinogenesis and of personalized cancer treatment is changing. With more understanding of the hallmarks of carcinogenesis and the role of genetics in the prevention and development of cancers, it is necessary to introduce learners to the complex interactions between cancer, nutrition, cell metabolism, immunity, inflammation, genetics, epigenetics, and the gut microbiome. This course addresses controversies as well — popular diets used by individuals interested in cancer prevention and recovery — offering guidelines to help determine whether following these diets is in a patient's best interest. This course presents the best evidence-based nutritional recommendations for a variety of cancers and preventive nutritional strategies.

1. Gain familiarity with the epidemiology of cancer.
2. Develop an understanding of the impact of socioeconomic, racial, mental health, and environmental disparities in cancer care.
3. Review hallmarks of carcinogenesis and nutritional factors that impact these hallmarks.
4. Review the interaction between genes, epigenetics, and nutrition.
5. Explore the rationale, evidence, clinical indications, and contraindications for various dietary patterns on cancer risk and in integrative cancer treatment - specifically carbohydrate and caloric restriction, a ketogenic diet, and fasting.
6. Gain an appreciation for the carcinogenic influence of insulin resistance and develop familiarity with ways to improve insulin sensitivity.
7. Evaluate the anti-cancer potential for various dietary phytonutrients and dietary supplements through an analysis of current scientific and clinical evidence.
8. Apply nutritional information that is specific to cancer types, namely breast, colorectal, and prostate cancers, through a review of summarized clinical evidence and with clinical scenarios, advising virtual patients about nutritional strategies.
9. Gain insight into evidenced nutritional and physical activity recommendations used for risk reduction and health optimization in cancer survivors.

https://awcim.arizona.edu/online_courses/nut_cancer.html

The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Arizona College of Medicine - Tucson designates this Enduring Material for a maximum of 12.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accessibility Statement
 
University of Arizona College of Medicine - Tucson Office of Continuing Medical Education is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME activity coordinator.

Mitigation of Relevant Financial Relationships

University of Arizona College of Medicine - Tucson Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.